Musculoskeletal disorders, affecting as many as 1.3 billion people worldwide, are the leading cause of disability and impose a substantial health and socioeconomic burden. Despite the high prevalence of these conditions, translational research in this field is far from optimal, highlighting the need for stronger collaboration between basic and clinical scientists. This paper, authored by members of the basic and clinical action groups of the European Calcified Tissue Society (ECTS) and endorsed by the Board of the ECTS, examines the key barriers to effective translational research in musculoskeletal diseases, including clinician workload, differences in professional language and culture, physical distance between research sites, and insufficient interdisciplinary funding. Through interviews with eight institutional managers across five European countries, we observed that in some institutions, the collaboration between basic scientists and clinicians was regarded as no concern (but with room for improvement), and in most institutions it was recognised as a serious issue. We found consensus on the importance of collaboration yet identified discrepancies in the provision of structural and financial support. Based on these findings, we propose strategic initiatives to bridge the gap between basic and clinical research. Suggested measures include dedicated translational funding, integrated research facilities, collaborative scientific forums, strategic collaborations, establishment of physician-scientists, and, finally, bringing basic and clinical researchers together in the same building or even in a combined department. Notable successes, such as the development of the anti-osteoporotic drugs, romosozumab and denosumab, underscore the value of a coordinated approach and exemplify how shared insights between laboratory research and clinical practice can lead to impactful therapeutic advances. Moving forward, we advocate for institutional commitments to foster a robust translational research environment, as well as tailored funding initiatives to support such efforts. This paper serves as a call for discussion and action to enhance interdisciplinary cooperation to advance musculoskeletal medicine and improve outcomes for patients with debilitating musculoskeletal diseases.

1st Department of Propaedeutic and Internal Medicine Endocrinology Unit LAIKO University Hospital National and Kapodistrian University of Athens Athens Greece

Department of Endocrinology 424 Military General Hospital Thessaloniki Greece

Department of Pathology Odense University Hospital Odense Denmark

Department of Rheumatology Amsterdam UMC Amsterdam The Netherlands

Department of Trauma and Orthopaedic Surgery Division of Orthopaedics University Medical Center Hamburg Eppendorf Hamburg Germany

Institute of Comparative Molecular Endocrinology Ulm University Ulm Germany

Laboratory of Molecular Physiology of Bone Institute of Physiology of the Czech Academy of Sciences Prague 4 Czech Republic

MABlab ULR 4490 Rheumatology Department University of Lille CHU Lille F 59000 Lille France

Pathology Research Unit Department of Clinical Research University of Southern Denmark Campusvej 55 5230 Odense M Denmark

See more in PubMed

Safiri S, Kolahi AA, Cross M, Hill C, Smith E, Carson-Chahhoud K, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad A, Kaufman J, Sepidarkish M, Shakouri SK, Hoy D, Woolf AD, March L, Collins G, Buchbinder R (2021) Prevalence, deaths, and disability-adjusted life years due to musculoskeletal disorders for 195 countries and territories 1990–2017. Arthritis Rheumatol 73(4):702–714. 10.1002/art.41571 PubMed

Nguyen AT, Aris IM, Snyder BD, Harris MB, Kang JD, Murray M, Rodriguez EK, Nazarian A (2024) Musculoskeletal health: an ecological study assessing disease burden and research funding. Lancet Reg Health Am 29:100661. 10.1016/j.lana.2023.100661 PubMed PMC

Zhu Z, Yu P, Wu Y, Wu Y, Tan Z, Ling J, Ma J, Zhang J, Zhu W, Liu X (2023) Sex specific global burden of osteoporosis in 204 countries and territories, from 1990 to 2030: an age-period-cohort modeling study. J Nutr Health Aging 27(9):767–774. 10.1007/s12603-023-1971-4 PubMed

Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11(8):669–674. 10.1007/s001980070064 PubMed

Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68(3):577–589. 10.1086/318811 PubMed PMC

Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532–1543. 10.1056/NEJMoa1607948 PubMed

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417–1427. 10.1056/NEJMoa1708322 PubMed

Geusens P, Appelman-Dijkstra N, Lems W, van den Bergh J (2023) Romosozumab for the treatment of postmenopausal women at high risk of fracture. Expert Opin Biol Ther 23(1):11–19. 10.1080/14712598.2022.2152320 PubMed

Anastasilakis AD, Tsourdi E (2024) The story of sclerostin inhibition: the past, the present, and the future. Hormones (Athens). 10.1007/s42000-023-00521-y PubMed

Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San Martin J, Dansey R (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11(5):401–419. 10.1038/nrd3705 PubMed

Kendler DL, Cosman F, Stad RK, Ferrari S (2022) Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther 39(1):58–74. 10.1007/s12325-021-01936-y PubMed PMC

Polyzos SA, Makras P, Tournis S, Anastasilakis AD (2019) Off-label uses of denosumab in metabolic bone diseases. Bone 129:115048. 10.1016/j.bone.2019.115048 PubMed

Moverare-Skrtic S, Henning P, Liu X, Nagano K, Saito H, Borjesson AE, Sjogren K, Windahl SH, Farman H, Kindlund B, Engdahl C, Koskela A, Zhang FP, Eriksson EE, Zaman F, Hammarstedt A, Isaksson H, Bally M, Kassem A, Lindholm C, Sandberg O, Aspenberg P, Savendahl L, Feng JQ, Tuckermann J, Tuukkanen J, Poutanen M, Baron R, Lerner UH, Gori F, Ohlsson C (2014) Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med 20(11):1279–1288. 10.1038/nm.3654 PubMed PMC

Zerhouni EA (2005) US biomedical research: basic, translational, and clinical sciences. JAMA 294(11):1352–1358. 10.1001/jama.294.11.1352 PubMed

Segal RL, Lewek MD, McCulloch K, Mercer VS (2011) The necessity for effective interaction between basic scientists and rehabilitation clinicians. Cells Tissues Organs 193(5):290–297. 10.1159/000323676 PubMed PMC

Ayers D, Day PJ (2015) Systems medicine: the application of systems biology approaches for modern medical research and drug development. Mol Biol Int 2015:698169. 10.1155/2015/698169 PubMed PMC

Maier D (2017) Applying systems medicine in the clinic. Curr Opin Syst Biol 3:77–87. 10.1016/j.coisb.2017.04.014

Restifo LL, Phelan GR (2011) The cultural divide: exploring communication barriers between scientists and clinicians. Dis Model Mech 4(4):423–426. 10.1242/dmm.008177 PubMed PMC

Filewod NC, Batt J, Kapus A, Szaszi K, Fairn GD, Slutsky AS, Lee WL (2018) Should basic science matter to clinicians? Lancet 391(10119):410–412. 10.1016/S0140-6736(18)30199-5 PubMed

Kabo FW, Cotton-Nessler N, Hwang Y, Levenstein MC, Owen-Smith J (2014) Proximity effects on the dynamics and outcomes of scientific collaborations. Res Policy 43(9):1469–1485. 10.1016/j.respol.2014.04.007

Kabo F, Hwang Y, Levenstein M, Owen-Smith J (2015) Shared paths to the lab. Environ Behav 47(1):57–84. 10.1177/0013916513493909

Kassirer JP (2010) Teaching clinical reasoning: case-based and coached. Acad Med 85(7):1118–1124. 10.1097/acm.0b013e3181d5dd0d PubMed